Vland Biotech (603739)
SSE · 603739
Market Cap$3.2B
Revenue$1.4B
Employees1522
Listed OnSSE
Ticker603739
CEO / ExecMr. Gang Chen
HeadquartersQingdao
MarketMainland China
Websitewww.vlandgroup.com
Overview
Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodie
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.